Fidaxomicin Tablet, Film Coated
Product Images NDC 60505-4833

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fidaxomicin (NDC 60505-4833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-20s.jpg (Btl Lbl 20s)

Label for Fidaxomicin Tablets, 200 mg, oral film-coated tablets. The package contains 20 tablets. Manufactured by Apotex Inc., Toronto, Ontario, Canada, and labeled for Apotex Corp., Weston, Florida. Storage instructions specify keeping the product at 20°C to 25°C with permitted excursions between 15°C to 30°C. Includes an NDC barcode and Rx Only designation.*

FDA Label Image

Ctn-lbl-20s.jpg (Ctn Lbl 20s)

Folded carton packaging label for Fidaxomicin Tablets 200 mg, oral film-coated tablets. The label displays the product name and strength prominently on front and side panels. It includes storage instructions, manufacturer details (Apotex Inc., Toronto, Canada; Apotex Corp., Weston, FL), and general warnings. The package holds 20 tablets, with NDC 60505-4833-2 and Rx only designation.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of Fidaxomicin, illustrating the arrangement of its molecular components as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.